The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
about
Wikidata as a semantic framework for the Gene Wiki initiativeLiterature information in PubChem: associations between PubChem records and scientific articlesEndothelinDrugCentral: online drug compendiumIDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug dataExtracellular nicotinamide phosphoribosyltransferase, a new cancer metabokineGPCRdb: the G protein-coupled receptor database - an introductionPubChem BioAssay: 2017 updateThe ChEMBL database in 2017Size distribution of function-based human gene sets and the split-merge modelCentral nervous system toxicity of mefenamic acid overdose compared with other NSAIDs: an analysis of cases reported to the United Kingdom National Poisons Information ServicePrivileged Structures Revisited.The Chemistry Development Kit (CDK) v2.0: atom typing, depiction, molecular formulas, and substructure searchingExercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.mutLBSgeneDB: mutated ligand binding site gene DataBase.The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.Pharmacogenomics of off-target adverse drug reactions.Drug repurposing from the perspective of pharmaceutical companies.The oxidative stress theory of disease: levels of evidence and epistemological aspects.The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.An S-warfarin and AZD1981 interaction: in vitro and clinical pilot data suggest the N-deacetylated amino acid metabolite as the primary perpetrator.The use of incretins and fractures - a meta-analysis on population-based real life data.Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data.Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns.Identification of novel inhibitors of the amino acid transporter B0 AT1 (SLC6A19), a potential target to induce protein restriction and to treat type 2 diabetes.Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel-group, phase I study in healthy subjects.First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasisRelaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.Last rolls of the yoyo: Assessing the human canonical protein count.Nutraceuticals in hypercholesterolaemia: an overview.The potential health effects of dietary phytoestrogensLack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult womenPharmacokinetics of obinutuzumab in Chinese patients with B-cell lymphomas.Influence of inflammation and nitric oxide upon platelet aggregation following deposition of diesel exhaust particles in the airways.A sphingosine-1-phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigrationHead-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injuryDetermining Cysteines Available for Covalent Inhibition Across the Human Kinome.A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3.Population pharmacokinetics of rituximab in patients with diffuse large B-cell lymphoma and association with clinical outcome
P2860
Q23712646-2367A4A7-EE16-417A-BCB8-BADE31F2CE16Q24658479-2AA040BF-BF57-447E-9EBC-8A359CF827A6Q26767156-9E081861-3C2F-49D5-8EFF-175B1D9DDD61Q27697588-252E79F3-0D02-462B-A472-F13CBD933D12Q27902312-F4EDB200-5602-4D89-ADDC-8529540AF708Q28069876-90152CBE-BD2B-4A11-9EFB-6D8B927CD251Q28077608-D3EEB14C-FCE3-41EB-8A6D-38A0852DF33AQ28555205-77FE3928-BFF6-4FA8-95F3-8DE33F1AEC37Q28584450-877FD8EC-D7EB-4043-89CA-75EE2022210AQ28595808-E2281543-E1D4-4EEC-8434-2FB96AB84FE8Q29248481-D099273D-31AF-4B46-A72A-28DCFEC1B37CQ30101030-A4D228D1-C1CD-4B6C-9420-DE73FBA87E1EQ30149558-F0BC90F1-31DA-4C04-AE75-5FBE2B437AB1Q30238666-6B44B1A2-5021-4446-BDF2-AB27D0B82531Q30395862-FEF5A0DA-4338-4ED9-BFC7-23516EB12C49Q30397640-C69B05A9-ECBB-458D-B97A-05009723C6BDQ30400366-3EA6DD9E-EE43-4A31-9FC3-E8A1EF60E955Q30400634-909C0890-CEF0-4BCC-B3B2-784A4C3270D3Q30489579-1D2DA29F-498D-457B-835C-33A1F39C7AE6Q31122398-4BC8EA8F-B7CD-4073-B76E-CC6828629A2EQ31123470-69D84042-DE7E-468E-AA2A-F40B92C841EBQ31138952-CC411610-1312-4115-A1D6-8BD96AB6DF1CQ31147482-EE4D4AA1-0DF2-4247-BEED-3B3EC2D550DEQ31202630-80A66941-E0CA-47D2-A0F6-B1F3F577B392Q32182366-06769CCA-394B-473D-AB12-BC10F59AF56EQ33434017-64DA75E2-8F46-432D-9F7D-80EA3789CB8EQ33593619-F6678443-84B3-4854-B8AF-9007EFEC8BD4Q33593625-13A58603-95F2-4D5D-9352-A3A8153D58C4Q33606810-93A48743-C539-406B-B96B-7C5AB3637157Q33672226-ED2A5997-2D5A-4EB3-A0BA-CF310953A5DEQ33676445-9816DF89-6E77-45D9-A19B-BDEB55957910Q33676455-06457328-BCF4-4A78-A002-C8ECBF9521F3Q33780895-8DD4D298-0E43-4F7D-B1AB-CDC00721C8ADQ33780903-F3A2EF96-A6E4-4031-B086-31B5B5AD173AQ33784212-2E9AA9D1-19D7-4B30-97DF-9DE1ED9B1BE3Q33784217-21EEFA95-F53B-47E3-9733-944C206D0B87Q33826729-05011181-EBE7-4753-ADED-FD2678634439Q33859476-5027064F-038A-4B6E-B599-366A7DA761D3Q33903698-846F4225-A6CF-4D53-9DAD-5484A8376CCEQ33903709-E35F146C-21F6-4927-86FC-52D03391DA94
P2860
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@ast
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@en
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@nl
type
label
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@ast
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@en
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@nl
prefLabel
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@ast
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@en
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@nl
P2093
P2860
P50
P3181
P356
P1476
The IUPHAR/BPS Guide to PHARMA ...... otein targets and 6000 ligands
@en
P2093
Doriano Fabbro
Helen E Benson
John A Peters
John C McGrath
O Peter Buneman
William A Catterall
P2860
P304
P3181
P356
10.1093/NAR/GKV1037
P407
P50
P577
2015-10-12T00:00:00Z